Incidence of chemotherapy-related cardiac dysfunction in cancer patients

CONCLUSION: Our meta-analysis unveiled a definitive overall incidence rate of chemotherapy-related cardiac dysfunction in cancer patients. In addition, it was found that the risk of developing this condition escalates within the initial 6 months postchemotherapy, subsequently tapering off to become statistically insignificant after a duration of 6 years.PMID:38634453 | DOI:10.1002/clc.24269

Source: Clinical Genitourinary Cancer - April 18, 2024 Category: Cancer & Oncology Authors: Hai-Wei Deng Rui Fan Yuan-Sheng Zhai Jie Li Zhi-Bin Huang Long-Yun Peng Source Type: research